Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pancreatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 4Neoplasms 3Colorectal Neoplasms 3Lung Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms 2Sarcoma 1Rectal Neoplasms 1Pancreatic Cancer Resectable 1Lymphangioleiomyomatosis 1Leukemia, Lymphocytic, Chronic, B-Cell 1Gliosarcoma 1Glioblastoma 1Colonic Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1COVID-19 1Breast Neoplasms, Male 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1Arthritis, Rheumatoid 1Anatomic Stage I Breast Cancer AJCC v8 1Adenocarcinoma of Lung 1

Interventions

Taxes 2Standard of Care 2Practice Guidelines as Topic 2Paclitaxel 2palbociclib 1nilotinib 1Telemedicine 1Rifaximin 1Radiation Dose Hypofractionation 1Letrozole 1Interviews as Topic 1Hydroxychloroquine 1Early Intervention, Educational 1Docetaxel 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anatomic Stage I Breast Cancer AJCC v8 × Hydroxychloroquine × Clear all
NCT03774472 2025-02-17

Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer

M.D. Anderson Cancer Center

Phase 1/2 Completed
15 enrolled 11 charts
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡